Editorial: "Stardust gastric mucosa" - A novel and consistent marker of vonoprazan safety during follow-up?

Aliment Pharmacol Ther. 2021 Jan;53(1):196-197. doi: 10.1111/apt.16198.

Authors

Maxime Luu^{1

2}, Ines Ben Ghezala^{1

2}, Marc Bardou^{1

2

3}

Affiliations

¹ CIC1432, Plurithematic Unit, INSERM, Dijon, France.
² Clinical Investigation Center, Plurithematic Unit, Dijon-Bourgogne University Hospital, Dijon, France.
³ Gastroenterology Department, Bourgogne University Hospital, Dijon, France.

PMID: 33333602
DOI: 10.1111/apt.16198

No abstract available

Publication types

Editorial
Comment

MeSH terms

Follow-Up Studies
Gastric Mucosa*
Humans
Incidence
Propensity Score
Pyrroles*
Risk Factors
Sulfonamides

Substances

1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine
Pyrroles
Sulfonamides